Cell LineInformation:
Designations: 22Rv1Organism: Homo sapiens (human)Tissue: carcinoma; prostateMorphology: epithelialGrowth properties: adherentTumorigenic: yes, forms tumors in nude miceAntigen expression: prostate specific antigen (PSA)DoublingTime: 40 hoursReceptors expressed: androgenDepositors: J.W. Jacobberger22Rv1 is a human prostate carcinoma epithelial cell line derived from a xenograft that was serially propagated in mice after castration-induced regression and relapse of the parental, androgen-dependent CWR22 xenograft. The cell line expresses prostate specific antigen. Growth is stimulated by epidermal growth factor (EGF) but is not inhibited by transforming growth factor beta-1 (TGF beta- 1).
The Transfection Reagent:
22Rv1 Cell Avalanche™ Transfection Reagent is a new class of unique chemical formulations specifically formulated and optimized for transfecting 22Rv1 cells. The proprietary formulation of lipids and polymers ensures the highest possible transfection efficiencies and viabilities for 22Rv1 cells. For details of the developing process of this reagent, please go to: How did EZ Biosystems develop Avalanche™ Cell type/cell line specific transfection reagent series?
Features:
- Unique formulation-maximize transfection performance in 22Rv1 cells.
- Highest efficiency to ensure experimental success
- Lowest Cellular Toxicity-maintain cell density and reduce experimental biases
- 0.5 ml is able to transfect about 1000 wells of 24-well plate
- Deliver single or multiple plasmids
- Reproducible: due to highly controlled chemical synthesis of each of the ingredients, the reagent forms uniformly sized complex particles with nucleic acids. With optimized protocol, our reagent will ensure the reproducible highest transfection results.
- Economical: High efficiency means less amount of nucleic acid & reagent is needed
- Developed and manufactured by EZ Biosystems
